PCE Data Lower Than Expected, NVO Falls on New Obesity Drug, AFRM Upgraded
Description
Jenny Horne joins the Futures show with live reaction to the latest PCE inflation data. November rate rose just 0.1% from October, but on an annual basis checked in at 2.4% On the stock front, Novo Nordisk (NVO) slid sharply after disappointing clinical data for its new obesity drug CagriSema. And, Affirm (AFRM) got a bullish call from the analyst community.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe
Download the iOS app - https://apps.apple.com/us/app/schwab-...
Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-...
Watch on Sling - https://watch.sling.com/1/asset/19192...
Watch on Vizio - https://www.vizio.com/en/watchfreeplu...
Watch on DistroTV - https://www.distro.tv/live/schwab-net...
Follow us on X – / schwabnetwork
Follow us on Facebook – / schwabnetwork
Follow us on LinkedIn - / schwab-network
About Schwab Network - https://schwabnetwork.com/about
United States
